(3S,5R,9S,11S,12R)-5-[(2R)-butan-2-yl]-N-[(3R,5R,6S)-5-[(2S,3S,5R)-5-[(2S,3R,5R)-4-[(2S,3S)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-3,5-dihydroxyoxan-2-yl]oxy-3,4-dihydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-2-(hydroxymethyl)-6-methyloxan-3-yl]-11-[(2R,3S,5S)-5-ethyl-3,4-dihydroxyoxolan-2-yl]oxy-3,9-dihydroxy-12-methyl-7-oxotetradecanamide

C48H85NO24 — CID 158989730

IUPAC(3S,5R,9S,11S,12R)-5-[(2R)-butan-2-yl]-N-[(3R,5R,6S)-5-[(2S,3S,5R)-5-[(2S,3R,5R)-4-[(2S,3S)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-3,5-dihydroxyoxan-2-yl]oxy-3,4-dihydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-2-(hydroxymethyl)-6-methyloxan-3-yl]-11-[(2R,3S,5S)-5-ethyl-3,4-dihydroxyoxolan-2-yl]oxy-3,9-dihydroxy-12-methyl-7-oxotetradecanamide
SMILESCC[C@@H]1O[C@@H](O[C@@H](C[C@H](O)CC(=O)C[C@@H](C[C@H](O)CC(=O)N[C@H]2C(CO)O[C@@H](C)[C@H](O[C@@H]3OC(C)[C@H](O[C@@H]4OC[C@@H](O)C(O[C@@H]5OCC(O)(CO)[C@@H]5O)[C@H]4O)C(O)[C@@H]3O)C2O)[C@H](C)CC)[C@H](C)CC)[C@@H](O)C1O
InChIInChI=1S/C48H85NO24/c1-8-20(4)24(11-25(52)13-27(54)14-30(21(5)9-2)70-46-37(60)34(57)29(10-3)69-46)12-26(53)15-32(56)49-33-31(16-50)67-22(6)40(35(33)58)72-45-38(61)36(59)41(23(7)68-45)71-44-39(62)42(28(55)17-65-44)73-47-43(63)48(64,18-51)19-66-47/h20-24,26-31,33-47,50-51,53-55,57-64H,8-19H2,1-7H3,(H,49,56)/t20-,21-,22+,23?,24+,26+,27-,28-,29+,30+,31?,33+,34?,35?,36?,37+,38+,39-,40+,41+,42?,43-,44+,45+,46+,47+,48?/m1/s1
InChIKeyYACZSXNNXCXSLW-OXABMKFWSA-N
MW1060.19 g/mol
LogP-4.06
Rot. Bonds26

About (3S,5R,9S,11S,12R)-5-[(2R)-butan-2-yl]-N-[(3R,5R,6S)-5-[(2S,3S,5R)-5-[(2S,3R,5R)-4-[(2S,3S)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-3,5-dihydroxyoxan-2-yl]oxy-3,4-dihydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-2-(hydroxymethyl)-6-methyloxan-3-yl]-11-[(2R,3S,5S)-5-ethyl-3,4-dihydroxyoxolan-2-yl]oxy-3,9-dihydroxy-12-methyl-7-oxotetradecanamide

(3S,5R,9S,11S,12R)-5-[(2R)-butan-2-yl]-N-[(3R,5R,6S)-5-[(2S,3S,5R)-5-[(2S,3R,5R)-4-[(2S,3S)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-3,5-dihydroxyoxan-2-yl]oxy-3,4-dihydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-2-(hydroxymethyl)-6-methyloxan-3-yl]-11-[(2R,3S,5S)-5-ethyl-3,4-dihydroxyoxolan-2-yl]oxy-3,9-dihydroxy-12-methyl-7-oxotetradecanamide (PubChem CID 158989730) has the molecular formula C48H85NO24 and a molecular weight of 1060.19 g/mol. Its IUPAC name is (3S,5R,9S,11S,12R)-5-[(2R)-butan-2-yl]-N-[(3R,5R,6S)-5-[(2S,3S,5R)-5-[(2S,3R,5R)-4-[(2S,3S)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-3,5-dihydroxyoxan-2-yl]oxy-3,4-dihydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-2-(hydroxymethyl)-6-methyloxan-3-yl]-11-[(2R,3S,5S)-5-ethyl-3,4-dihydroxyoxolan-2-yl]oxy-3,9-dihydroxy-12-methyl-7-oxotetradecanamide.

Molecular Properties

Compound Name(3S,5R,9S,11S,12R)-5-[(2R)-butan-2-yl]-N-[(3R,5R,6S)-5-[(2S,3S,5R)-5-[(2S,3R,5R)-4-[(2S,3S)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-3,5-dihydroxyoxan-2-yl]oxy-3,4-dihydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-2-(hydroxymethyl)-6-methyloxan-3-yl]-11-[(2R,3S,5S)-5-ethyl-3,4-dihydroxyoxolan-2-yl]oxy-3,9-dihydroxy-12-methyl-7-oxotetradecanamide
PubChem CID158989730
Molecular FormulaC48H85NO24
Molecular Weight1060.19 g/mol
Exact Mass1059.55
IUPAC Name(3S,5R,9S,11S,12R)-5-[(2R)-butan-2-yl]-N-[(3R,5R,6S)-5-[(2S,3S,5R)-5-[(2S,3R,5R)-4-[(2S,3S)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-3,5-dihydroxyoxan-2-yl]oxy-3,4-dihydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-2-(hydroxymethyl)-6-methyloxan-3-yl]-11-[(2R,3S,5S)-5-ethyl-3,4-dihydroxyoxolan-2-yl]oxy-3,9-dihydroxy-12-methyl-7-oxotetradecanamide
SMILESCC[C@@H]1O[C@@H](O[C@@H](C[C@H](O)CC(=O)C[C@@H](C[C@H](O)CC(=O)N[C@H]2C(CO)O[C@@H](C)[C@H](O[C@@H]3OC(C)[C@H](O[C@@H]4OC[C@@H](O)C(O[C@@H]5OCC(O)(CO)[C@@H]5O)[C@H]4O)C(O)[C@@H]3O)C2O)[C@H](C)CC)[C@H](C)CC)[C@@H](O)C1O
InChIInChI=1S/C48H85NO24/c1-8-20(4)24(11-25(52)13-27(54)14-30(21(5)9-2)70-46-37(60)34(57)29(10-3)69-46)12-26(53)15-32(56)49-33-31(16-50)67-22(6)40(35(33)58)72-45-38(61)36(59)41(23(7)68-45)71-44-39(62)42(28(55)17-65-44)73-47-43(63)48(64,18-51)19-66-47/h20-24,26-31,33-47,50-51,53-55,57-64H,8-19H2,1-7H3,(H,49,56)/t20-,21-,22+,23?,24+,26+,27-,28-,29+,30+,31?,33+,34?,35?,36?,37+,38+,39-,40+,41+,42?,43-,44+,45+,46+,47+,48?/m1/s1
InChIKeyYACZSXNNXCXSLW-OXABMKFWSA-N
XLogP-4.06
TPSA392.23 Ų
H-Bond Donors14
H-Bond Acceptors24
Rotatable Bonds26
Heavy Atoms73
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001060.19
LogP ≤ 5-4.06
H-Bond Donors ≤ 514
H-Bond Acceptors ≤ 1024

Analyze (3S,5R,9S,11S,12R)-5-[(2R)-butan-2-yl]-N-[(3R,5R,6S)-5-[(2S,3S,5R)-5-[(2S,3R,5R)-4-[(2S,3S)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-3,5-dihydroxyoxan-2-yl]oxy-3,4-dihydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-2-(hydroxymethyl)-6-methyloxan-3-yl]-11-[(2R,3S,5S)-5-ethyl-3,4-dihydroxyoxolan-2-yl]oxy-3,9-dihydroxy-12-methyl-7-oxotetradecanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (3S,5R,9S,11S,12R)-5-[(2R)-butan-2-yl]-N-[(3R,5R,6S)-5-[(2S,3S,5R)-5-[(2S,3R,5R)-4-[(2S,3S)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-3,5-dihydroxyoxan-2-yl]oxy-3,4-dihydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-2-(hydroxymethyl)-6-methyloxan-3-yl]-11-[(2R,3S,5S)-5-ethyl-3,4-dihydroxyoxolan-2-yl]oxy-3,9-dihydroxy-12-methyl-7-oxotetradecanamide?
The IUPAC name of (3S,5R,9S,11S,12R)-5-[(2R)-butan-2-yl]-N-[(3R,5R,6S)-5-[(2S,3S,5R)-5-[(2S,3R,5R)-4-[(2S,3S)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-3,5-dihydroxyoxan-2-yl]oxy-3,4-dihydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-2-(hydroxymethyl)-6-methyloxan-3-yl]-11-[(2R,3S,5S)-5-ethyl-3,4-dihydroxyoxolan-2-yl]oxy-3,9-dihydroxy-12-methyl-7-oxotetradecanamide (CID 158989730) is (3S,5R,9S,11S,12R)-5-[(2R)-butan-2-yl]-N-[(3R,5R,6S)-5-[(2S,3S,5R)-5-[(2S,3R,5R)-4-[(2S,3S)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-3,5-dihydroxyoxan-2-yl]oxy-3,4-dihydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-2-(hydroxymethyl)-6-methyloxan-3-yl]-11-[(2R,3S,5S)-5-ethyl-3,4-dihydroxyoxolan-2-yl]oxy-3,9-dihydroxy-12-methyl-7-oxotetradecanamide.
What is the SMILES notation for (3S,5R,9S,11S,12R)-5-[(2R)-butan-2-yl]-N-[(3R,5R,6S)-5-[(2S,3S,5R)-5-[(2S,3R,5R)-4-[(2S,3S)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-3,5-dihydroxyoxan-2-yl]oxy-3,4-dihydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-2-(hydroxymethyl)-6-methyloxan-3-yl]-11-[(2R,3S,5S)-5-ethyl-3,4-dihydroxyoxolan-2-yl]oxy-3,9-dihydroxy-12-methyl-7-oxotetradecanamide?
The canonical SMILES for (3S,5R,9S,11S,12R)-5-[(2R)-butan-2-yl]-N-[(3R,5R,6S)-5-[(2S,3S,5R)-5-[(2S,3R,5R)-4-[(2S,3S)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-3,5-dihydroxyoxan-2-yl]oxy-3,4-dihydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-2-(hydroxymethyl)-6-methyloxan-3-yl]-11-[(2R,3S,5S)-5-ethyl-3,4-dihydroxyoxolan-2-yl]oxy-3,9-dihydroxy-12-methyl-7-oxotetradecanamide is CC[C@@H]1O[C@@H](O[C@@H](C[C@H](O)CC(=O)C[C@@H](C[C@H](O)CC(=O)N[C@H]2C(CO)O[C@@H](C)[C@H](O[C@@H]3OC(C)[C@H](O[C@@H]4OC[C@@H](O)C(O[C@@H]5OCC(O)(CO)[C@@H]5O)[C@H]4O)C(O)[C@@H]3O)C2O)[C@H](C)CC)[C@H](C)CC)[C@@H](O)C1O.
What is the InChIKey of (3S,5R,9S,11S,12R)-5-[(2R)-butan-2-yl]-N-[(3R,5R,6S)-5-[(2S,3S,5R)-5-[(2S,3R,5R)-4-[(2S,3S)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-3,5-dihydroxyoxan-2-yl]oxy-3,4-dihydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-2-(hydroxymethyl)-6-methyloxan-3-yl]-11-[(2R,3S,5S)-5-ethyl-3,4-dihydroxyoxolan-2-yl]oxy-3,9-dihydroxy-12-methyl-7-oxotetradecanamide?
The InChIKey is YACZSXNNXCXSLW-OXABMKFWSA-N. The full InChI is InChI=1S/C48H85NO24/c1-8-20(4)24(11-25(52)13-27(54)14-30(21(5)9-2)70-46-37(60)34(57)29(10-3)69-46)12-26(53)15-32(56)49-33-31(16-50)67-22(6)40(35(33)58)72-45-38(61)36(59)41(23(7)68-45)71-44-39(62)42(28(55)17-65-44)73-47-43(63)48(64,18-51)19-66-47/h20-24,26-31,33-47,50-51,53-55,57-64H,8-19H2,1-7H3,(H,49,56)/t20-,21-,22+,23?,24+,26+,27-,28-,29+,30+,31?,33+,34?,35?,36?,37+,38+,39-,40+,41+,42?,43-,44+,45+,46+,47+,48?/m1/s1.
What are the key properties of (3S,5R,9S,11S,12R)-5-[(2R)-butan-2-yl]-N-[(3R,5R,6S)-5-[(2S,3S,5R)-5-[(2S,3R,5R)-4-[(2S,3S)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-3,5-dihydroxyoxan-2-yl]oxy-3,4-dihydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-2-(hydroxymethyl)-6-methyloxan-3-yl]-11-[(2R,3S,5S)-5-ethyl-3,4-dihydroxyoxolan-2-yl]oxy-3,9-dihydroxy-12-methyl-7-oxotetradecanamide?
(3S,5R,9S,11S,12R)-5-[(2R)-butan-2-yl]-N-[(3R,5R,6S)-5-[(2S,3S,5R)-5-[(2S,3R,5R)-4-[(2S,3S)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-3,5-dihydroxyoxan-2-yl]oxy-3,4-dihydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-2-(hydroxymethyl)-6-methyloxan-3-yl]-11-[(2R,3S,5S)-5-ethyl-3,4-dihydroxyoxolan-2-yl]oxy-3,9-dihydroxy-12-methyl-7-oxotetradecanamide has a molecular weight of 1060.19 g/mol, XLogP of -4.06, 26 rotatable bonds, 14 hydrogen bond donors, and 24 hydrogen bond acceptors.
Where does this data come from?
All data for (3S,5R,9S,11S,12R)-5-[(2R)-butan-2-yl]-N-[(3R,5R,6S)-5-[(2S,3S,5R)-5-[(2S,3R,5R)-4-[(2S,3S)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-3,5-dihydroxyoxan-2-yl]oxy-3,4-dihydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-2-(hydroxymethyl)-6-methyloxan-3-yl]-11-[(2R,3S,5S)-5-ethyl-3,4-dihydroxyoxolan-2-yl]oxy-3,9-dihydroxy-12-methyl-7-oxotetradecanamide is sourced from PubChem (CID 158989730), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).